Therefore, new treatment approaches of VS with severe PTBE may lie in the reduction of VEGF secretion or the blockage of its receptors (e.g., flk1 and KDR), as they may reduce tumor neovascularization, tumor growth capacity, and tumor invasion capacity. Here, VEGFA is linked to neoplasm.